CD44 and breast cancer: A clinical study conducted using breast cancer (BC) tissue from 44 women and tissue from 25 healthy women suggested that the number of stem cells (CD44 high and CD24 low) was significantly associated with high expression levels of Wnts and β-catenin, thereby indicating a potential for targeting Wnt signaling for treatment of breast cancer [125].